Matinas BioPharma Holdings (MTNB) Treasury Shares (2018)

Matinas BioPharma Holdings (MTNB) reported Treasury Shares of $192222.0 for Q3 2018, up 188.33% quarter-over-quarter from $66667.0 in Q2 2018.

Matinas BioPharma Holdings (MTNB) Treasury Shares (2018) Analysis & Trends

Matinas BioPharma Holdings (MTNB) has 1 years of Treasury Shares data on file, last reported at $192222.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	700,000.00
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Matinas BioPharma Holdings	4.60 Mn	2.15 Mn	-	-

Download Data